How is the "Ozempic-Face" phenomenon and 2026's weight-loss surge driving a boom in facial fat grafting?
In 2026, the global success of GLP-1 weight-loss medications has created an unexpected "side effect" that is reshaping the cheek augmentation market: "Ozempic-Face." As millions of people achieve rapid weight loss, they often experience a dramatic depletion of facial fat, leading to a hollowed, aged appearance in the cheek area. To combat this, 2026 has seen a record-breaking demand for...
0 Comments 0 Shares 19 Views 0 Reviews